With over 30 years of medical and clinical research experience, Dr. Chawla partners with the chemo experts at The Sarcoma Center. He continues his pioneering work as a leader in experiential treatments and clinical trial drugs using some of the new advanced therapies for many of his cancer patients.
His efforts have resulted in breakthroughs in experiential therapies, including:
- Immunotherapy Targeted Therapy
- Long Term Interferon Treatment
- Malignant Tumor Removal
- Therapeutic Tumor Vaccines
Our integrated treatment approach may include options for experiential therapies as part of a patient’s comprehensive cancer care. The Sarcoma Oncology Center collaborates with other centers to provide PD1 and PDL1 Inhibitor treatment and Hyperthermia Therapy for cancer.
We partner with you for the most effective treatment plan and treatment outcome. As with any treatment, experiential therapies might have side effects. However, by working closely with you, we help minimize any discomfort that arises.
Over the next five years, Dr. Chawla’s medical research will continue its focus on the development of:
- Cancer gene therapy
- Vaccines
- Immunotherapies (treatments that use the body’s own defenses to combat cancer)
- Anti-angiogenic agents (drugs to block the development of blood vessels and starve the tumor)
All his research is focused on sarcomas, offering patients the very best treatment options available today.